Amgen Inc (AMGN): Today's Featured Health Care Winner

Amgen ( AMGN) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.9%. By the end of trading, Amgen rose 95 cents (1.3%) to $74.80 on light volume. Throughout the day, 3.3 million shares of Amgen exchanged hands as compared to its average daily volume of 4.4 million shares. The stock ranged in a price between $73.78-$74.81 after having opened the day at $74.08 as compared to the previous trading day's close of $73.85. Other companies within the Health Care sector that increased today were: Sunshine Heart ( SSH), up 93.4%, Amerigroup Corporation ( AGP), up 38%, Telik ( TELK), up 36.8%, and IsoRay ( ISR), up 21.1%.

Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. Amgen has a market cap of $57.81 billion and is part of the drugs industry. The company has a P/E ratio of 17.2, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 15.8% year to date as of the close of trading on Friday. Currently there are 10 analysts that rate Amgen a buy, one analyst rates it a sell, and 13 rate it a hold.

TheStreet Ratings rates Amgen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, attractive valuation levels and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the negative front, Luminex Corporation ( LMNX), down 17.9%, K-V Pharmaceutical Company ( KV.B), down 16.9%, BSD Medical Corporation ( BSDM), down 13.6%, and Amyris ( AMRS), down 12%, were all losers within the health care sector with Allergan ( AGN) being today's health care sector loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec